Research on TIM-3 and Alzheimer's treatment is charting new territory in the quest for effective therapies against this debilitating disease.TIM-3, an immune checkpoint molecule, has emerged as a significant factor influencing how the brain's immune cells, known as microglia, combat the accumulation of amyloid plaques associated with Alzheimer's.